Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis
Phase of Trial: Phase III
Latest Information Update: 31 Oct 2009
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 31 Oct 2009 New trial record.